Cleared Special

K212246 - Exofin Precision Pen (FDA 510(k) Clearance)

Sep 2021
Decision
52d
Days
Class 2
Risk

K212246 is an FDA 510(k) clearance for the Exofin Precision Pen. This device is classified as a Tissue Adhesive For The Topical Approximation Of Skin (Class II - Special Controls, product code MPN).

Submitted by Chemence Medical, Inc. (Alpharetta, US). The FDA issued a Cleared decision on September 9, 2021, 52 days after receiving the submission on July 19, 2021.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.4010. Docket Number: 2006p-0071 - May 5, 2008 - Reclassified From Class 3 Pma To Class 2 510(k)..

Submission Details

510(k) Number K212246 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 19, 2021
Decision Date September 09, 2021
Days to Decision 52 days
Submission Type Special
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code MPN - Tissue Adhesive For The Topical Approximation Of Skin
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.4010
Definition Docket Number: 2006p-0071 - May 5, 2008 - Reclassified From Class 3 Pma To Class 2 510(k).